A Study of CM310 in Subjects With Moderate to Severe Asthma
NCT05186909
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
CM310
OTHER:
Placebo
Sponsor
Keymed Biosciences Co.Ltd